Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Chagas disease
2010 Standout
The Brazilian health system: history, advances, and challenges
2011 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
A Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria
2008
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD
2004
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
2002
Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe
2002
Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation
2014
Hepatocellular carcinoma
2003 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Delayed graft function in kidney transplantation
2004 Standout
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
2000 Standout
Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis
2000
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years
2003
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era
2010
Evaluation and stages of surgical innovations
2009 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
2006
Chronic obstructive pulmonary disease
2003
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
2011 Standout
Characterization of Small Nodules in Cirrhosis by Assessment of Vascularity: The Problem of Hypovascular Hepatocellular Carcinoma *
2005
The Influence of Hospital Volume on Survival after Resection for Lung Cancer
2001
Hepatocellular carcinoma
2012 Standout
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
Surgeon Volume and Operative Mortality in the United States
2003 Standout
Lung Transplantation: A Decade of Experience
1999
Critical use of extended criteria donor liver grafts in adult-to-adult whole liver transplantation: A single-center experience
2008
Sarcoidosis
2013 Standout
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
2015
Management of Hepatocellular Carcinoma *
2005 Standout
Estimates of Early Death, Acute Liver Failure, and Long-term Mortality Among Live Liver Donors
2011
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
2008
Model for end-stage liver disease (MELD) and allocation of donor livers
2003 Standout
Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis
2008
Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy
2004
Hematopoietic Stem-Cell Transplantation
2006 Standout
Disease-Specific Survival Benefit of Lung Transplantation in Adults: A National Cohort Study
2009
Characteristics and Outcomes of Patients With Sarcoidosis Listed for Lung Transplantation
2001
A RANDOMIZED, DOUBLE-BLINDED COMPARISON OF THYMOGLOBULIN VERSUS ATGAM FOR INDUCTION IMMUNOSUPPRESSIVE THERAPY IN ADULT RENAL TRANSPLANT RECIPIENTS1,2
1999
Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy
2000
Association Between Hospital and Surgeon Procedure Volume and Outcomes of Total Hip Replacement in the United States Medicare Population*
2001
Trends in Hospital Volume and Operative Mortality for High-Risk Surgery
2011 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Predicting in-hospital mortality in patients with cirrhosis: Results differ across risk adjustment methods #
2008
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
2009
Transplant tumor registry: donor related malignancies
2002
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi
2001
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Idiopathic pulmonary fibrosis
2011 Standout
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Organ Donation and Utilization in the United States, 1996–2005
2007
Sarcoidosis
2007 Standout
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives
2000
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Hepatocellular Carcinoma
2011 Standout
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
2006 Standout
Organ donation and transplantation trends in the United States, 2001
2003
Transplantation of Liver Grafts from Living Donors into Adults — Too Much, Too Soon
2001
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Hospital and Surgeon Procedure Volume as Predictors of Outcome Following Rectal Cancer Resection
2002
Predicting Survival in Idiopathic Pulmonary Fibrosis
2001
Delayed Access and Survival in Idiopathic Pulmonary Fibrosis
2011
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Hepatocellular Carcinoma
2019 Standout
Predicting Mortality in Patients With Sarcoidosis Awaiting Lung Transplantation
2003
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Thromboendarterectomy
2005
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Cardiac Allograft Vasculopathy
2008
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Standing the test of time: Outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment
2014
Physical Activity and Public Health in Older Adults
2007 Standout
Risk of End-Stage Renal Disease Following Live Kidney Donation
2014 Standout
The influence of clinical variables on hospital costs after orthotopic liver transplantation
1999
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Disparidades nas filas para transplantes de órgãos nos estados brasileiros
2010
Idiopathic Pulmonary Fibrosis
2018 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
The Effect of Clustering of Outcomes on the Association of Procedure Volume and Surgical Outcomes
2003
Works of Erick B. Edwards being referenced
Liver transplantation for hepatocellular carcinoma: The MELD impact
2004
ANTILYMPHOCYTE INDUCTION THERAPY IN CADAVER RENAL TRANSPLANTATION
1997
Center-Specific Graft and Patient Survival Rates
1998
The Effect of the Volume of Procedures at Transplantation Centers on Mortality after Liver Transplantation
1999
Geographic differences in access to transplantation in the United States
2003
Utilization of Extended Donor Criteria Liver Allograft: Is the Elevated Risk of Failure Independent of the Model for End-Stage Liver Disease Score of the Recipient?
2006
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
1998
REASONS FOR NON-USE OF RECOVERED KIDNEYS: THE EFFECT OF DONOR GLOMERULOSCLEROSIS AND CREATININE CLEARANCE ON GRAFT SURVIVAL
2004
Influence of HLA Matching on Thoracic Transplant Outcomes
1996
The Effect of Transplant Center Volume on Cardiac Transplant Outcome
1994
The impact of MELD on OPTN liver allocation: preliminary results.
2002
Liver and intestine transplantation
2003
The Effect of the Volume of Procedures at Transplantation Centers on Mortality After Liver Transplantation
2000